Mark Austin
Director Financiero/CFO en PERSPECTIVE THERAPEUTICS, INC. .
Fortuna: 134 448 $ al 30/04/2024
Cargos activos de Mark Austin
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/07/2017 | - |
| Director Financiero/CFO | 01/07/2017 | - | |
| Secretario Corporativo | 15/09/2020 | - |
Historial de carrera de Mark Austin
Antiguos cargos conocidos de Mark Austin.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
KPMG Advisory SP ZOO Spolka Komandytowa
 KPMG Advisory SP ZOO Spolka Komandytowa Investment ManagersFinance Part of KPMG CEE Holdings Ltd., KPMG Advisory Sp zoo Spolka Komandytowa provides financial advisory services. The company is based in Warsaw, Poland. | Corporate Officer/Principal | 01/01/2009 | 01/07/2017 |
IsoRay, Inc.
 IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Comptroller/Controller/Auditor | 24/07/2017 | - |
| Director Financiero/CFO | 24/07/2017 | - | |
| Secretario Corporativo | 03/12/2018 | - |
Formación de Mark Austin.
| Santa Clara University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
| Polonia | 2 |
Operativa
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 2 |
| Corporate Secretary | 2 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Health Technology |
KPMG Advisory SP ZOO Spolka Komandytowa
KPMG Advisory SP ZOO Spolka Komandytowa Investment ManagersFinance Part of KPMG CEE Holdings Ltd., KPMG Advisory Sp zoo Spolka Komandytowa provides financial advisory services. The company is based in Warsaw, Poland. | Finance |
- Bolsa de valores
- Insiders
- Mark Austin
- Experiencia